STOCK TITAN

Theravance Biopharma: Newtyn reports zero-share stake

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Theravance Biopharma, Inc. (TBPH) is the issuer in an exit ownership filing by Newtyn Management, LLC, investment manager for Newtyn TE Partners, LP and Newtyn Partners, LP. As of September 30, 2026, Newtyn Management reported zero ordinary shares beneficially owned; each partnership also held zero shares. The report lists zero sole and shared voting and dispositive power and zero percent ownership.

Beneficially owned ordinary shares 0 shares Newtyn Management, as of September 30, 2026
Ownership percentage 0.0% Newtyn Management
Voting power 0 shares Sole and shared voting power reported by Newtyn Management
Dispositive power 0 shares Sole and shared dispositive power reported by Newtyn Management
beneficially own regulatory
"may be deemed to beneficially own the zero Ordinary Shares"
Beneficially own means having the economic rights and risks of a security—such as the right to receive dividends, sell the shares, or profit from price changes—whether or not your name appears on the official share register. Think of it like renting a car: you use it and reap the benefits even if the title lists someone else. Investors care because beneficial ownership determines who truly controls value, must be disclosed under securities rules, and can signal potential influence or trading activity that affects a stock’s price.
exit filing regulatory
"this is an exit filing"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many TBPH ordinary shares did Newtyn Management beneficially own?

Newtyn Management reported zero ordinary shares beneficially owned as of September 30, 2026. Newtyn TE Partners, LP and Newtyn Partners, LP each held zero ordinary shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





G8807B106

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: See Item 2 for additional information.


SCHEDULE 13G



Newtyn Management, LLC
Signature:/s/ Eugene Dozortsev
Name/Title:Eugene Dozortsev, Authorized Signatory
Date:11/16/2026

Keep reading